1227862-58-9

Upstream product

• 1227862-56-7 1-(5-nitropyridin-2-yl)-4-hydroxy-4-phenylpiperidine 
• 40807-61-2 4-hydroxy-4-phenylpiperidin 
• 4548-45-2 2-chloro-5-nitropyridine 

Downstream Products

• 1227861-08-6 C₂₇H₂₅N₃O₂S 
• 927989-62-6 6‐(4‐phenylpiperazin‐1‐yl)pyridin‐3‐amine 
• 1227862-68-1 6-(4-(hydroxy(phenyl)methyl)piperidin-1-yl)pyridin-3-amine 
• 344940-45-0 4-(5-amino-pyridin-2-yl)-[1,4]diazepane-1-carboxylic acid tert-butyl ester 
• 71086-99-2 ethyl 5-amino-1H-indole-2-carboxylate 
• 869108-96-3 Methyl 4-(5-aminopyridin-2-yloxy)benzenecarboxylate 
• 1227862-64-7 6-(4-phenethylpiperidin-1-yl)pyridin-3-amine 
• 1227862-66-9 6-(4-(benzyloxy)piperidin-1-yl)pyridin-3-amine 
• 119285-07-3 4-(5-aminopyridin-2-yl)piperazine-1-carboxylic acid tert-butyl ester 
• 1227862-70-5 6-[hexahydro-5-oxo-4-(phenylmethyl)-1H-1,4-diazepin-1-yl]pyridin-3-amine 
• 1227862-31-8 4-phenyl-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-5'-ylamine 
• 1227932-06-0 Tert-butyl 2-(2-oxo-2-(4-(5-(2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)oxazole-5-carboxamido)pyridin-2-yl)piperazin-1-yl)ethyl)benzoate 
• 1227932-10-6 Methyl 3-((4-(5-(2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)oxazole-5-carboxamido)pyridin-2-yl)-2-oxopiperazin-1-yl)methyl)benzoate 
• 1227932-11-7 N-[6-(4-(o-tolylsulfonyl)piperazin-1-yl)pyridin-3-yl]-2-(piperidin-1-yl)-4-(trifluoromethyl)oxazole-5-carboxamide 

Relevant academic research and scientific papers

INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE

The present invention relates to novel heterocyclic compounds as diacylglycerol acyltransferase (“DGAT”) inhibitors, pharmaceutical compositions comprising the heterocyclic compounds and the use of the compounds for treating or preventing a cardiovascular disease, a metabolic disorder, obesity or an obesity-related disorder, diabetes, dyslipidemia, a diabetic complication, impaired glucose tolerance or impaired fasting glucose. An illustrative compound of the invention is shown below: formula (I).

INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE

The present invention relates to novel heterocyclic compounds as diacylglycerol acyltransferase ( DGAT ) inhibitors, pharmaceutical compositions comprising the heterocyclic compounds and the use of the compounds for treating or preventing a cardiovascular disease, a metabolic disorder, obesity or an obesity-related disorder, diabetes, dyslipidemia, a diabetic complication, impaired glucose tolerance or impaired fasting glucose. An illustrative compound of the invention is shown below: (We bring to your attention that the illustrative compound of the invention is not provided on this electronic version as it is provided in the abstract of the paper copy)

Inhibitors of Diacylglycerol Acyltransferase

Provided herein are amides containing at least a four ring structure, which are inhibitors of diacylglycerol acyltransferase and are useful for the treatment of diseases such as, for example, obesity, type II diabetes mellitus and metabolic syndrome.